Please try another search
Devonian Health Group Inc. engages in the development of botanical drugs. Its lead product candidate is Thykamine, completed Phase IIa clinical trial product for the treatment of ulcerative colitis and atopic dermatitis. The company also develops Pantoprazole Magnesium for the treatment of gastric; Cleo-35 for the treatment of hormonal acne in women; and value-added products for dermo-cosmetics. In addition, the company acquires drug and health product licenses; and distributes pharmaceutical products. Devonian Health Group Inc. was incorporated in 2015 and is headquartered in Québec, Canada.
Name | Age | Since | Title |
---|---|---|---|
Francois Malouin | - | 2019 | Member of Scientific Advisory Board |
Louis Flamand | - | 2017 | Member of Scientific Advisory Board & Independent Director |
George G. Zhanel | - | 2019 | Member of Scientific Advisory Board |
John Trant | - | 2019 | Member of Scientific Advisory Board |
Ian D. R. Landells | - | 2019 | Member of Clinical Dermatology Advisory Board |
Sam Hanna | - | 2019 | Member of Clinical Dermatology Advisory Board |
David C. Baker | 60 | 2023 | Independent Non-Executive Chairman |
Suha Jabaji | - | 2019 | Member of Scientific Advisory Board |
Jerry Tan | - | 2019 | Member of Clinical Dermatology Advisory Board |
Jaggi Rao | - | 2019 | Member of Clinical Dermatology Advisory Board |
Andre P. Boulet | 65 | 2015 | Chief Scientific Officer & Director |
Luc D. Gregoire | 64 | 2023 | President, CEO & Director |
Jean Forcione | - | 2023 | Independent Director |
Edouard Dahl | - | 2023 | Independent Director |
Kathryn J. Gregory | 61 | 2024 | Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review